JONATHAN SILVERSTEIN Insider Trading $ARQT Arcutis Biotherapeutics, Inc.
Get free email notifications about insider trading for JONATHAN SILVERSTEIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JONATHAN SILVERSTEIN. JONATHAN SILVERSTEIN is Director in AVANIR PHARMACEUTICALS, INC. ($AVNR) and in GLAUKOS Corp ($GKOS) and Director in GLAUKOS Corp ($GKOS) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in AVEDRO INC ($AVDR) and Director in Roka BioScience, Inc. ($ROKA) and Director in scPharmaceuticals Inc. ($SCPH) and Director in Audentes Therapeutics, Inc. ($BOLD) and Director in resTORbio, Inc. ($TORC) and Director in Arcutis Biotherapeutics, Inc. ($ARQT).
JONATHAN SILVERSTEIN in Arcutis Biotherapeutics, Inc.
Trading Symbol: ARQTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JONATHAN SILVERSTEIN: Director
Holdings: 4,267,564 shares
Latest Transaction: Oct 06 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JONATHAN SILVERSTEIN in Arcutis Biotherapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TORC, ARQT, BOLD, AVNR, AVDR, GKOS, ICPT, SCPH, ROKA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 06 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | P | 25.00 | 296,000 | 7,400,000 | 902,286 | 606.3 K to 902.3 K (+48.82 %) |
Oct 06 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | P | 25.00 | 200,000 | 5,000,000 | 4,267,564 | 4.1 M to 4.3 M (+4.92 %) |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 27.61 | 24,000 | 662,640 | 24,000 | |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 429,786 | 0 | 0 | |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 859,573 | 0 | 0 | |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 2,825,603 | 0 | 0 | |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 429,786 | 0 | 606,286 | 176.5 K to 606.3 K (+243.50 %) |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 859,573 | 0 | 4,067,564 | 3.2 M to 4.1 M (+26.79 %) |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 2,825,603 | 0 | 3,207,991 | 382.4 K to 3.2 M (+738.94 %) |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | P | 17.00 | 176,500 | 3,000,500 | 176,500 | 0 to 176.5 K |
Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | P | 17.00 | 382,388 | 6,500,596 | 382,388 | 0 to 382.4 K |
Page: 1